Status:
COMPLETED
Regional Observatory on Metabolic Syndrome- LAZIO
Lead Sponsor:
AstraZeneca
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of the study, is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.
Eligibility Criteria
Inclusion
- lipid profile in the last year
- Signed informed consent
Exclusion
- Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
- Pregnancy or breast feeding
- Subject who are unwilling or unable to provide the informed consent
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
1574 Patients enrolled
Trial Details
Trial ID
NCT00689455
Start Date
October 1 2007
End Date
December 1 2008
Last Update
December 3 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Rieti, Italy
2
Research Site
Rome, Italy
3
Research Site
Viterbo, Italy